Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹9960 Cr.
Stock P/E
58.5
P/B
5.5
Current Price
₹1033.7
Book Value
₹ 189.5
Face Value
10
52W High
₹1183.2
52W Low
₹ 538.2
Dividend Yield
0%

Yatharth Hospital Overview

Business

Yatharth Hospital & Trauma Care Services Ltd. is an India-based company operating multi-specialty tertiary care hospitals. The company provides a comprehensive range of healthcare services, including inpatient and outpatient consultations, emergency care, advanced surgical procedures, diagnostic services, and critical care across various medical disciplines such. Its core business model involves owning and operating hospitals and generating revenue through fees charged for medical services provided to patients, including direct payments, corporate tie-ups, and health insurance reimbursements.

Revenue Mix

While specific revenue contribution percentages are not provided, the company's primary revenue streams typically originate from:

Inpatient Services: This segment usually constitutes the largest portion of revenue for multi-specialty hospitals, encompassing room charges, surgical fees, consultation fees, and procedures for admitted patients.

Outpatient Services: Includes consultations, minor procedures, and diagnostic tests performed on an outpatient basis.

Ancillary Services: Comprises revenues from pharmacies, pathology, radiology, and other support services.

Given its focus on tertiary care and trauma services, a significant portion of its revenue is likely derived from complex surgical procedures and critical care.

Industry

The Indian healthcare industry is characterized by strong growth driven by increasing disposable incomes, rising health awareness, and growing insurance penetration. It is a fragmented market, but with increasing consolidation among organized private players. Yatharth Hospital is positioned as a regional multi-specialty hospital chain, primarily serving the Delhi NCR region and Uttar Pradesh. It aims to provide quality, accessible, and affordable healthcare, catering to the growing middle-class population that seeks advanced medical facilities beyond public healthcare. It competes with both large national hospital chains and smaller, localized healthcare providers.

MOAT

Yatharth's competitive advantages are likely to include:

Brand Reputation & Trust: Building patient trust and a strong local brand in its operational geographies over time, particularly for specific specialties or emergency services.

Doctor Relationships: Ability to attract and retain experienced medical professionals and specialists, which is crucial for patient flow and quality of care.

High Capital Intensity: The significant upfront capital investment required to set up and equip multi-specialty hospitals acts as a barrier to entry for new competitors.

Localized Network Effect: Establishing a presence and referral network within its target regions.

Growth Drivers

Key factors that can drive Yatharth Hospital's growth over the next 3-5 years include:

Rising Healthcare Demand: India's large and growing population, increasing life expectancy, and higher prevalence of chronic diseases will continue to drive demand for quality healthcare services.

Increased Health Insurance Penetration: Growing adoption of public and private health insurance schemes makes quality healthcare more accessible and affordable for a wider population.

Capacity Expansion: Strategic expansion into new geographies or increasing bed capacities and service offerings in existing hospitals.

Medical Tourism: Potential to attract patients from neighboring regions or countries seeking quality healthcare at competitive costs.

Focus on Specialties: Expanding into high-demand and high-margin medical specialties.

Risks

Key business risks for Yatharth Hospital include:

Regulatory & Pricing Risks: Government interventions in healthcare pricing (e.g., price caps on procedures, medicines, or medical devices) could impact profitability.

Intense Competition: The hospital sector is highly competitive, facing pressure from established national chains, regional players, and single-specialty hospitals.

Doctor Attrition & Retention: High reliance on skilled medical professionals means losing key doctors can significantly impact patient flow and reputation.

High Capital Expenditure & Debt: Expansion plans often require significant capital investment, which, if funded by debt, can increase financial leverage and interest costs.

Operational Risks: Risks associated with medical errors, equipment failures, litigation, and maintaining high-quality patient care standards.

Economic Downturn: Could lead to reduced discretionary spending on elective procedures and impact patient volumes.

Management & Ownership

Yatharth Hospital is typically promoter-led, with the founding family or individuals playing a significant role in its strategic direction and operations. Promoters usually maintain a substantial ownership stake post-listing, aligning their interests with the company's long-term growth. The management team is expected to be comprised of professionals with experience in hospital administration, finance, and medical operations, focused on operational efficiency, clinical excellence, and strategic expansion.

Outlook

Yatharth Hospital operates in a sector with significant tailwinds from India's growing healthcare needs and increasing affordability of private medical services. The company's focus on multi-specialty tertiary care in its chosen geographies positions it to capitalize on this demand. However, success will depend on its ability to navigate an increasingly competitive and regulatory-sensitive environment. Efficient execution of expansion plans, maintaining high standards of medical care, attracting and retaining top medical talent, and prudent financial management will be critical to its sustained growth and profitability. The balance between aggressive expansion and maintaining operational efficiency will define its trajectory in the coming years.

Yatharth Hospital Share Price

Live · BSE / NSE · Inception: 2008
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Yatharth Hospital Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 178 212 218 219 233 259 279 320 342 393
Other Income 6 4 3 4 4 8 9 8 7 4
Total Income 183 215 221 223 237 267 289 328 349 397
Total Expenditure 131 158 163 164 175 193 215 246 262 301
Operating Profit 52 57 58 59 62 74 74 82 87 96
Interest 0 3 2 2 1 0 0 1 5 7
Depreciation 8 11 16 17 13 15 19 24 30 28
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 44 43 40 40 49 59 55 57 52 61
Provision for Tax 6 13 9 10 10 17 14 14 7 16
Profit After Tax 38 30 31 30 39 42 41 43 45 45
Adjustments -0 0 0 0 -0 -0 -0 2 3 2
Profit After Adjustments 38 30 31 30 39 42 41 45 48 47
Adjusted Earnings Per Share 4.5 3.5 3.6 3.2 4 4.4 4.3 4.7 4.9 4.9

Yatharth Hospital Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 102 146 229 401 520 671 886 1207 1334
Other Income 0 0 1 2 3 16 11 26 28
Total Income 102 146 229 403 523 686 897 1233 1363
Total Expenditure 82 108 161 289 385 489 655 903 1024
Operating Profit 20 39 69 114 138 198 241 330 339
Interest 7 20 20 23 23 11 13 19 13
Depreciation 8 21 21 28 28 29 57 88 101
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0
Profit Before Tax 5 -2 28 63 88 157 172 224 225
Provision for Tax 1 -0 9 19 22 42 41 53 51
Profit After Tax 4 -2 20 44 66 114 131 170 174
Adjustments -0 1 -1 0 0 0 -0 5 7
Profit After Adjustments 4 -1 18 44 66 114 131 175 181
Adjusted Earnings Per Share 0.6 -0.2 2.8 6.7 10 13.3 13.5 18.2 18.8

Yatharth Hospital Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 56 54 72 117 183 874 1605 1781
Minority's Interest 3 8 8 0 0 0 32 27
Borrowings 146 157 164 207 201 75 1 227
Other Non-Current Liabilities 10 8 9 -1 -5 -8 -10 37
Total Current Liabilities 42 60 55 97 100 67 85 184
Total Liabilities 257 287 309 421 478 1009 1713 2255
Fixed Assets 164 189 251 303 299 442 605 1250
Other Non-Current Assets 69 69 9 8 3 57 252 293
Total Current Assets 24 29 49 109 176 510 856 712
Total Assets 257 287 309 421 478 1009 1713 2255

Yatharth Hospital Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 13 0 2 5 12 37 108 360
Cash Flow from Operating Activities 17 39 44 60 64 -3 131 205
Cash Flow from Investing Activities -78 -43 -21 -52 -20 -226 -388 -598
Cash Flow from Financing Activities 47 5 -19 -1 -18 304 509 254
Net Cash Inflow / Outflow -13 1 3 7 26 75 253 -140
Closing Cash & Cash Equivalent 0 2 5 12 37 113 360 220

Yatharth Hospital Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 0.61 -0.2 2.77 6.74 10.04 13.33 13.55 18.2
CEPS(Rs) 1.89 2.94 6.13 10.99 14.24 16.75 19.48 26.79
DPS(Rs) 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 8.49 8.29 11.06 17.84 27.93 101.84 166.62 184.79
Core EBITDA Margin(%) 19.68 26.32 29.76 27.93 25.98 27.14 26.01 25.21
EBIT Margin(%) 11.68 11.84 21 21.39 21.23 25.1 20.8 20.08
Pre Tax Margin(%) 4.93 -1.7 12.3 15.74 16.85 23.39 19.39 18.52
PAT Margin (%) 3.91 -1.41 8.57 11.01 12.64 17.07 14.74 14.11
Cash Profit Margin (%) 12.14 13.17 17.56 17.97 17.93 21.44 21.2 21.38
ROA(%) 1.55 -0.76 6.57 12.11 14.64 15.4 9.59 8.58
ROE(%) 7.15 -3.74 30.91 46.65 43.87 21.65 10.53 10.06
ROCE(%) 5.4 7.53 19.3 27.07 26.88 23.97 14.35 13.3
Receivable days 42.75 36.03 42.83 55.67 67.76 91.08 108.91 102.24
Inventory Days 8.1 6.4 4.99 3.91 3.95 3.87 5.99 6.29
Payable days 489.53 331.95 165.15 134.8 153.39 138.44 60.31 108.23
PER(x) 0 0 0 0 0 31.3 31.35 33.91
Price/Book(x) 0 0 0 0 0 4.1 2.55 3.34
Dividend Yield(%) 0 0 0 0 0 0 0 0
EV/Net Sales(x) 1.77 1.36 0.86 0.78 0.56 5.11 4.13 4.92
EV/Core EBITDA(x) 8.9 5.16 2.88 2.74 2.11 17.34 15.14 17.98
Net Sales Growth(%) 0 43.41 56.59 75.33 29.77 28.88 32.07 36.31
EBIT Growth(%) 0 45.33 177.74 78.6 28.81 52.37 9.46 31.54
PAT Growth(%) 0 -151.62 1054.12 125.45 48.92 74.06 14.04 30.45
EPS Growth(%) 0 -132.72 1495.67 143.18 48.93 32.83 1.61 34.34
Debt/Equity(x) 2.96 3.4 2.57 2.21 1.44 0.1 0 0.14
Current Ratio(x) 0.57 0.48 0.9 1.13 1.77 7.59 10.12 3.87
Quick Ratio(x) 0.51 0.43 0.84 1.07 1.71 7.47 9.87 3.76
Interest Cover(x) 1.73 0.87 2.41 3.79 4.85 14.66 14.74 12.89
Total Debt/Mcap(x) 0 0 0 0 0 0.02 0 0.04

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +36% +32% +39% —
Operating Profit CAGR +37% +34% +37% —
PAT CAGR +30% +37% +53% —
Share Price CAGR +38% +39% — —
ROE Average +10% +14% +27% +21%
ROCE Average +13% +17% +21% +17%

Yatharth Hospital Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 55.8 %
FII 5.62 %
DII (MF + Insurance) 10.84 %
Public (retail) 27.74 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 66.5466.5466.5461.4461.6461.6461.6455.855.855.8
FII 3.994.896.289.784.454.346.56.185.255.62
DII 9.39.46.9811.2512.0512.078.6910.7811.1710.84
Public 20.1619.1620.217.5321.8521.9523.1727.2427.7927.74
Others 0000000000
Total 100100100100100100100100100100

Yatharth Hospital Peer Comparison

Hospital & Healthcare Services Edit Columns

Yatharth Hospital Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Yatharth Hospital Pros & Cons

Pros

  • Company has delivered good profit growth of 53% CAGR over last 5 years
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Company has a low return on equity of 14% over the last 3 years.
  • Debtor days have increased from 60.31 to 108.23days.
  • Stock is trading at 5.5 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp